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ABSTRACT 
 
White, Carla M. Audiologists’ Knowledge, Attitudes, and Practices Regarding 
Patients with Systemic Lupus Erythematosus and Hearing Loss. Unpublished 
Doctor of Audiology capstone research project, University of Northern 
Colorado, 2020. 
 
 
 Patients diagnosed with systemic lupus erythematosus (SLE) have a moderate 
to high risk of developing a sensorineural hearing loss. The purpose of this study was 
to identify the knowledge, the degree of confidence, and the clinical practices of 
audiologists and graduate students when providing audiological care to this 
population. An opportunity for the respondents to share clinical experiences and 
knowledge was also provided.  
 A sample of 77 respondents, 24 licensed audiologists and 53 graduate students, 
represented that audiologists are generally aware of the disease and that SLE can cause 
sensorineural hearing loss. Graduate students were more likely to learn about SLE 
from personal relationships, while licensed audiologists first learned of SLE from 
another health care professional. Outcomes also revealed that additional resources, 
such as a clinical protocol and a list of SLE support groups, are needed and have been 
requested by both respondent groups.  
Both licensed audiologists and graduate students are knowledgeable with SLE 
but are currently interested in clinical resources. There is an opportunity for additional 
research to create a more formal and finite protocol to be utilized when an audiologist 
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sees a patient with SLE. Further research should identify the appropriate actions an 
audiologist must complete in order to ensure that sufficient long-term audiologic care 
can be provided to patients diagnosed with systemic lupus erythematosus 
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CHAPTER I 
INTRODUCTION 
 
 Systemic lupus erythematosus (SLE), in short, can be described as increased 
autoimmune activity. While healthy and typical autoimmune responses are designated 
to attack foreign bodies and viruses present in the human body, healthy tissues, 
organs, and other bodily systems are targeted by the overactive immune system. A 
number of elements need to be taken in account when determining the cause of the 
disease manifestation. Factors causing the presentation of SLE symptoms include 
genetic makeup (Akirav et al., 2011; Anderson & Su, 2011), environmental events 
(Davidson & Diamond, 2014), or a combination of these two factors. Gender and race 
are known determinants: the majority of SLE patients are female, and higher rates of 
African Americans are diagnosed with the disease (Dragin et al., 2017). Pubescent 
development has a role in disease initiation; therefore, the majority of SLE patients are 
age 20 or older (Bovo et al., 2006). These characteristics of SLE can make it 
challenging for clinicians to confirm the presence of the disease. 
 Varying organ involvement is reported with each SLE patient, and the auditory 
system is one of the vulnerable structures. Researchers have distinguished a number of 
attributes associated with autoimmune-related hearing loss. If the patient does have 
autoimmune involvement within the auditory system, a bilateral high-frequency 
sensorineural hearing loss (SNHL) that is symmetrical in nature may develop.   
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 The majority of published work is quantitative in design. Researchers provide 
recommendations to audiologists in the counseling and care for SLE patients 
diagnosed with a hearing loss. For instance, these patients should pursue annual 
hearing evaluations in order to monitor the hearing loss. What remains to be analyzed 
is whether practicing audiologists are considering these recommendations. Research 
that is qualitatively designed may render valuable information related to how 
audiologists care and monitor SLE patients.  
Statement of the Problem  
 The general understanding of the connection between hearing loss and 
autoimmune responses related to SLE has been expanded upon through recent 
research. What should be answered is what are the clinical methods and protocols used 
by audiologists to evaluate and monitor autoimmune inner ear disease in SLE patients. 
Are audiologists practicing in the United States aware of the heterogeneous nature of 
SLE and that each SLE patient will have differing symptoms and secondary diagnoses 
that develop due to the autoimmune disease? Do audiologists stress the importance of 
annual hearing evaluations with this population due to unexpected flares or sudden 
rise of symptoms? What is the timeline of events for a patient needing a medical 
referral for SLE related hearing loss? How long is this process?  
Rationale 
 The purpose of this study was to evaluate the knowledge, attitudes, and 
practices of audiologists who see SLE patients for audiological evaluations. A survey 
was developed and was composed of sections to evaluate knowledge, attitudes, and 
practices. Additional demographic information was included, such as whether the 
audiologist was currently licensed and how many years they had been providing 
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audiological services. The purpose of the survey was to further inform best practices 
in hearing health care provided to patients with SLE.  
Research Questions  
Q1 What are the knowledge, attitudes, and practice patterns of currently 
practicing and experienced audiologists regarding patients with 
systemic lupus erythematosus?  
 
Q2 What are the knowledge, attitudes, and practice patterns of current 
audiology graduate students regarding patients with systemic lupus 
erythematosus?  
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CHAPTER II 
REVIEW OF THE LITERATURE 
 Systemic lupus erythematosus (SLE) is one of many autoimmune diseases that 
have yet to be fully understood. While this disease is known for its impact on organs 
such as the kidneys, skin, and heart, current research has identified the involvement 
and pathophysiology of SLE on the auditory system. Over the past 30 years, multiple 
groups of researchers have recognized the role of SLE in the onset of sensorineural 
hearing loss (SNHL), tinnitus, and vertigo. Furthermore, the limited pharmacological 
options intended to suppress the autoimmune activity of lupus have been found to 
have ototoxic effects. The purpose of this literature review is to describe the degree 
and prevalence of auditory impairment in SLE patients. The objective of this research 
design is to identify the degree of knowledge and the therapy methods that are utilized 
by audiologists within the United States.  
Autoimmune Diseases 
 Autoimmune diseases have been studied for centuries; however, this type of 
disease has yet to be fully understood. Due to the varying symptoms across patients, 
thorough evaluation is required in order to confirm an autoimmune disease diagnosis.  
Intensive testing includes multiple blood analyses to determine blood disorders and 
antibody levels of the immune system, urine analysis to decide kidney involvement, 
dermatological assessment to diagnose skin conditions, evaluation of reported pain 
and soreness in the joints, and possible neurological examinations (Al-Sukaini et al., 
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2014). It is crucial that clinicians in multiple fields, including audiologists, are 
informed of how this disease may impact the physiological and anatomy that falls 
within their professional area of expertise.  
 Autoimmune disease is characterized as an immune response that presents as 
an inflammatory response in either a concentrated area or within multiple systems of 
the body (Davidson & Diamond, 2001). Diagnoses that fall within the category of 
autoimmune diseases include Wedgener’s granulomatosis, rheumatoid arthritis, type II 
diabetes mellitus, Sjogrens disease, Cogan syndrome, and Susac syndrome.  
 While the integrity and health of the body depend on the proper functioning of 
the immune system, prolonged periods of increased immune activity can be 
detrimental (Davidson & Diamond, 2014). As Davidson and Diamond (2001) 
explained, a typical healthy immune response is initiated when the presence of foreign 
bodies, such as an infection or bacteria, has been identified. Davidson and Diamond 
stated that groups of T-cells, B cells, and monocytes attack the foreign bodies and 
clear away the debris. In autoimmune diseases, areas of healthy tissues are damaged 
by groups of overactive T-cells (Davidson & Diamond, 2001). In general, autoimmune 
diseases are distinguished by the increased immune activity as well as damage of 
healthy tissues. 
 Genetic studies have revealed that each disorder that falls under the 
autoimmune disease umbrella has a genetic element (Akirav et al., 2011; Anderson & 
Su, 2011). Deletion of a section of the autoimmune regulator (AIRE) gene or a defect 
of the Fas gene can lead to the development of a form of autoimmunity (Fleisher et al., 
2001; Grodzicky & Elkon, 2002). Additionally, the lack of the Foxp3 gene, a T-cell 
regulating gene, can result in an increased number of T-cells. In some cases, the 
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failure to remove dead material after an immune response, leading to an accumulation 
of material, causes an exaggerated immune response, a common feature of SLE 
(Lewis & Botto, 2006; Pettigrew et al., 2009).  
 Additional research has confirmed theories that autoimmunity can also be the 
result of environmental events (Davidson & Diamond, 2014). These alterations 
include gum infections (periodontal disease) and smoking (Klareskog et al., 2011) as 
well as ultraviolet light (Bijl & Kallenberg, 2006). Therefore, susceptibility to 
autoimmune diseases is attributed to genetic predispositions, environmental events, or 
a combination of the two (Davidson & Diamond, 2014). 
 The first signs of autoimmune disease development can occur at the age of 20 
years or older (Bovo et al., 2006). Though uncommon, patients under the age of 20 
have been diagnosed. Childhood-onset and juvenile-type SLE make up approximately 
10% to 20% of the SLE population with the majority being diagnosed between 12 and 
18 years of age (Silva et al., 2012). The majority of autoimmune diseases are more 
prevalent in females than males, a finding that is indicative of sexual hormone 
involvement (Davidson & Diamond, 2014). Studies have concluded that possessing 
two X chromosomes increases the susceptibility to autoimmune diseases (Smith-
Bouvier et al., 2008). This can be attributed to the greater number of genes located on 
the X-chromosome that are responsible for immunological development (Smith-
Bouvier et al., 2008).  
 Research completed by Dragin et al. (2017) reported that the expression of the 
AIRE gene, responsible for managing autoimmunity, is decreased in females after 
puberty. Further investigation suggests a possible relationship of the AIRE gene and 
estrogen, suggesting that as estrogen levels increase, AIRE gene expression is 
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suppressed (Dragin et al., 2017). Even with these recent findings, more research is 
required to better understand the complex relationship of gender, genetics, and 
autoimmune diseases.  
 Due to the complexity of these diseases, it is common to have a team of 
clinicians work together and provide therapeutic options. While treatment and care is 
typically provided at the discretion of a rheumatologist, patients diagnosed with 
autoimmune diseases are likely to be seen by hematologists, vascular care 
professionals, and audiologists. An overwhelming amount of evidence suggests that 
select autoimmune diseases negatively impact the auditory system and cause different 
degrees of hearing loss, affect the vestibular system, and are associated with a 
prevalence of tinnitus. This type of knowledge can be used to educate audiologists 
regarding the auditory structures that are impacted. As a result, an audiologist can 
select therapeutic options and additions to the audiometric test battery to provide the 
comprehensive medical surveillance and rehabilitative care this population requires.  
Systemic Lupus Erythematosus 
 “Lupus” is the latin term for “wolf” and was first used by Pierre Louis Alpheé 
Cazenave, a French physician, when he observed malar rashes in some SLE patients 
that resembled the shape and color of the bite of a wolf. (Chabner, 2013). 
“Erythematosus,” stemming from the root word “erythema,” is defined as redness of 
the skin (Kim & Werth, 2014). As mentioned earlier, the malar rash, or malar 
erythema, is a common feature of SLE and may be referred to as a “butterfly rash” 
(Kim & Werth, 2014, p. 37).  
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Diagnostic Criteria  
 The SLE is an autoimmune disease that is predominately diagnosed in the 
young (Batuecas-Caletrío et al., 2013). Features of this disease can vary extensively 
from patient to patient. Yu et al. (2014) published a review that discussed the most 
recent update to the diagnostic criteria for SLE by the Systemic Lupus International 
Collaborating Clinics (SLICC) in 2012. A diagnosis is determined if the individual 
satisfies at least four features that fall into the following categories: abnormal 
immunological features, hematologic disorder, renal disorders, serositis (inflammation 
of serous tissues that surround the heart, lungs, and abdomen), symptoms affecting the 
joints, and cutaneous disorders (Yu et al., 2014). According to the Rheumatology 
Boston weighted criteria, common features of SLE include positive antinuclear 
antibody (ANA) counts within the blood, cytopenia (reduced blood cell count), 
arthritis, malar rash across the face, and photosensitivity (Costenbader et al., 2002). 
These findings were based on the reported symptoms of SLE patients receiving care at 
Massachusetts General Hospital Rheumatology Clinic (Costenbader et al., 2002). Due 
to the considerable involvement of SLE throughout the body, the auditory system is at 
risk of a magnified inflammatory response.  
Prevalence  
 The Centers for Disease Control and Prevention have funded a number of 
registries, as well as longitudinal research, with the intention of identifying the 
prevalence of SLE in the United States in five regions: San Francisco County in 
California, Manhattan in New York, Fulton and DeKalb counties in Georgia, and 
Wayne and Washtenaw counties in Michigan (Dall’Era et al., 2017; Izmirly et al., 
2017; Lim et al., 2014; Somers et al., 2014). With these registries, the accuracy of the 
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outcomes is questionable and possibly underestimated due to the exclusion of patients 
within the Veterans Health Administration system (Izmirly et al., 2017), the limited 
hospitals reviewed due to other facilities that declined to participate (Izmirly et al., 
2017), unidentified SLE cases (Somers et al., 2014), and the retrospective nature of the 
research (Dall’Era et al., 2017; Lim et al., 2014; Somers et al., 2014). 
 Prevalence rates varied within each region. The highest value of 84.8 for every 
100,000 individuals was reported in San Francisco County between the years 2007 and 
2009 (Dall’Era et al., 2017). The prevalence rates were slightly lower in New York 
with amounts at 62.2 for every 100,000 Manhattan citizens between 2007 and 2009 
(Izmirly et al., 2017). Lim et al. (2014) reported rates in Georgia of 74.4 per 100,000 
and 72.8 per 100,000 in Michigan. In all of these studies, a greater prevalence was 
associated with women and individuals of African American background.  
 Other efforts have been devoted to the evaluation of SLE prevalence in the 
United States. Helmick et al. (2008) used the 2003-2005 National Health Interview 
Survey (NHIS) and determined that between 161,000 and 322,000 adults were living 
with the disease at the time. Outcomes from the efforts of the Centers for Disease 
Control and Prevention and NHIS provide a preliminary of the number of SLE 
patients; however, further investigation is required to establish definite prevalence 
rates. 
To evaluate of the prevalence of hearing loss in SLE patients, Rahne et al. 
(2017) compared 20 individuals with SLE to a control group that was matched for 
both gender and age. The SLE patients were assessed according to duration of SLE, 
what organs were impacted, the use of steroids over the time in which the disease had 
been treated, and the use of immunosuppressive medications. The hearing evaluation 
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completed with both participant groups included tympanometry, acoustic reflex 
testing, pure-tone audiometry, sentence testing with speech perception and word 
recognition, and distortion product otoacoustic emissions (OAEs). Pure-tone 
audiometric testing resulted in higher rates of SNHL associated with the SLE group 
compared to the control group. The results from the other tests in the audiometric test 
battery were not significantly different between the two groups. Rahne et al. 
interpreted these results to be the consequence of disease involvement affecting the 
stria vascularis, spiral ganglion cells, or hair cells, or the result of microinfarctions of 
temporal microvessels. From this research, it was estimated that there is a moderate to 
high association of hearing loss with SLE (Rahne et al., 2017). 
Temporal Bone Studies 
 Numerous auditory structures are impacted by SLE. Sone et al. (1999) 
evaluated the structural integrity of the temporal bones from seven patients, ages 14 to 
76 years, diagnosed with SLE. The presence of the stria vascularis, cochlear hair cells, 
and ganglion cells was measured. The degree of loss of each auditory structure varied 
by patient with case one having little involvement while cases three and seven showed 
high losses of these structures from the cochlear base to the apex.  
 Kariya et al. (2016) examined a larger participant pool of temporal bones: 15 
from SLE patients and an additional 17 bones that made up the age-matched control 
group (between 14 and 76 years of age). Kariya et al. concluded that the amount of 
stria vascularis tissue of all the cochlear turns was significantly reduced when 
compared to normal temporal bones (p < 0.05). Significant findings were also present 
with the degree of outer hair cell loss (p < 0.05). Inner hair cells were also impacted 
yet this was not statistically significant (p < 0.05). Within this study, the most severe 
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case was a 22-year-old woman with complete obliteration of cochlear structures such 
as the organ of Corti, stria vascularis, and basilar membrane. These structures were 
replaced with fibrous tissue left behind by the inflammatory response. In conclusion, 
the invasive nature of SLE can result in the irreversible deterioration of multiple 
auditory structures. Therefore, it is paramount that the audiologist promptly identifies 
the hearing loss.  
Hearing Loss Characteristics 
 Research completed in the late 1990s to today has identified varying degrees 
and types of SNHL associated with SLE. Studies have been designed to recruit SLE 
patients that are below the age in which presbycusis becomes a possible factor for the 
onset of the hearing loss. When identifying the most common symptoms impacting the 
auditory system, the researchers reported that prevalence of hearing loss due to SLE 
ranged from 6% to 70% (Di Stadio & Ralli, 2017). There is little agreement across the 
completed research studies about the range of frequencies that are impacted by SLE. 
Disease Duration  
 Variable outcomes are also reported when disease duration is compared to the 
degree of the hearing loss. The purpose of the study by Maciazczyk et al. (2011) was 
to identify whether there was a relationship between these two factors. Thirty-seven 
SLE patients were matched according to age and gender with a control group. The 
SLE patient group was then divided into three groups according to disease duration: 
five years or less, six to 10 years, and over 10 years. The mean age was 42.6 years for 
the first group, 51.6 years for the second group, and 52.8 years for the third group. To 
prevent the misinterpretation of hearing loss due to presbycusis rather than SLE, each 
group was divided further into younger and older groups. Therefore, a total of six 
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groups were evaluated. Maciazczyk et al. concluded that the duration of the disease 
had a greater impact on audiometric thresholds than did age. This allows researchers 
to rule out the role of presbycusis. Consequently, audiologists should be aware that 
patients diagnosed with SLE early in their lives exhibit significantly decreased 
auditory thresholds that are unrelated to presbycusis.  
Frequencies 
 Di Stadio and Ralli (2017) completed a meta-analysis of the literature with 
regard to SLE and the presence of SNHL. A prevalence rate of 65% for SNHL 
affecting the higher frequencies, specifically 4000 and 8000 Hz was identified. Abbasi 
et al. (2013) identified 12 of the 45 (26.7%) participants with SLE as having bilateral 
high-frequency SNHL. Roverano et al. (2006) established that of 31 patients with a 
mean age of 35 years, 66% had a bilateral SNHL in the higher frequencies. 
Additionally, Maciazczyk et al. (2011) reported that 28.6% of the recruited SLE 
patients had a high-frequency hearing loss when a standard audiometric battery was 
completed. In conclusion, the onset of a high-frequency hearing loss is an apparent 
characteristic of SNHL in individuals diagnosed with SLE.  
 Di Stadio and Ralli (2017) also reported that the second-most prevalent type of 
SNHL (32%) occurred within the mid-frequencies, which affected 2000 and 3000 Hz. 
Karatas et al. (2007) confirmed that 21% of the participants had a SNHL at 500, 1000, 
and 2000 Hz. These outcomes support the proposition that autoimmune-related 
hearing loss is not solely restricted to the higher frequencies.   
 Low-frequency SNHL occurred with a 3% prevalence rate in the published 
literature (Di Stadio & Ralli, 2017). Rahne et al. (2017) evaluated 58 patients with 
three autoimmune disorders, one of which included SLE. Results established that SLE 
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patients were predisposed to the development of low-frequency SNHL. Karabulut et 
al. (2010) suspected that the decreased audiometric thresholds in this frequency range 
could be indicative of either endolymphatic or cochlear hydrops. Altogether, some 
SLE patients may have a SNHL affecting the frequencies between 4000 and 8000 Hz, 
while others have a SNHL impacting frequencies below 1000 Hz. This may be 
attributed to the heterogenous nature of SLE in which each SLE patient can have 
differing symptoms. 
 While results from multiple studies suggest that the SNHL is focused within a 
specific range of frequencies, other studies have identified SNHL across a range of 
frequencies. Andonopoulos et al. (1995) determined a significant decrease in auditory 
thresholds at 125 and 500 Hz in the study group comprised of participants between the 
ages 16 and 59 years. A second finding revealed a decrease in the higher frequencies 
was observed in the group that was referred to as the young patients and incorporated 
SLE patients between the ages of 16 and 29 years. Karabulut et al. (2010), after 
completing pure-tone audiometry, found significantly decreased auditory thresholds at 
250, 500, 1000, 2000 10,000, and 12,000 Hz. These findings indicate that both low 
and high frequencies could be significantly impacted. In conclusion, a comprehensive 
review of the literature demonstrates that high-frequency SNHLs are frequently 
identified. However, reduced auditory thresholds have been identified in other 
conventional audiometric frequency ranges. 
Progressive Versus Static 
Hearing Loss 
 An additional feature of SNHL in SLE patients that needs to be evaluated is 
the time course: progressive or static. While this information is limited in its relation 
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to systemic lupus, a few studies explored the longitudinal status of the hearing loss. 
An early study by Sperling et al. (1996) associated a slowly progressive SNHL due to 
the mechanisms of SLE. Cordeschi et al. (2004) had similar results with the use of 
transient evoked otoacoustic emissions (TEOAEs). In antithesis of these findings, 
Maciazczyk et al. (2011) determined that the hearing losss were static and not 
susceptible to further decline.  
Sudden Sensorineural 
Hearing Loss 
 The SNHL with a sudden onset is a possible, but uncommon, event associated 
with SLE. In a number of patient cases, the sudden hearing loss was the initial 
symptom of SLE (Green & Miller, 2001; Kastanioudakis et al., 2002). Lin et al. 
(2013) identified greater incidence rates of sudden SNHL in SLE patients when 
compared to participants without the autoimmune disease. Furthermore, SLE patients 
over the age of 35 years had a greater incidence of sudden SNHL (Lin et al., 2013).  
 Researchers have been aware of this feature of hearing loss associated with 
SLE since the 1990s. One theory supporting the sudden onset includes a condition that 
is frequently comorbid with SLE: antiphospholipid syndrome (APS). The APS is 
known to cause microthrombosis of the stria vascularis (Hisashi et al., 1993). A 
second theory states that the activity of the autoimmune antibodies can result in the 
diminished numbers of inner ear proteins (Suzuki et al., 1997). 
 An additional feature to note is whether the patient with SLE has any comorbid 
conditions, such as rheumatoid arthritis. Xie et al. (2019) focused on the likelihood of 
recovery from a sudden SNHL in patients with both SLE and rheumatoid arthritis. 
Findings suggest that the prognosis of this particular set of patients was low and that 
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there was a low likelihood that hearing sensitivity would recover. Riera et al. (2019) 
identified the same outcome in patients with SLE and APS. Overall, the additional 
comorbidities can result in a poorer prognosis in terms of sudden SNHL.  
 While the incidence is not high, the sudden onset of SNHL should be 
recognized as a potential feature in an SLE case. In addition, if a sudden SNHL is 
confirmed in a patient, the audiologist and otolaryngologist must rule out the 
likelihood of autoimmunity as the cause of the hearing loss. Lin et al. (2013) 
recommended that SLE patients should have regular evaluations for the early 
determination of autoimmune-related sudden SNHL. 
Bilateral Versus Unilateral 
Hearing Loss 
 Within the literature, studies have explored whether SNHL in SLE manifests 
predominately as a bilateral loss or as a unilateral loss. The majority of published work 
has identified the prevalence of bilateral SNHL within this specific population (Abbasi 
et al., 2013; Kastanioudakis et al., 2002; Maciazczyk et al., 2011; Roverano et al., 
2006; Sperling et al., 1996). However, a number of research studies have identified 
cases of both bilateral and unilateral SNHL (Gomides et al., 2007; Karatas et al., 
2007). Gomides et al. (2007) identified three patients with a bilateral loss and four 
patients with unilateral losses, approximately 57% of the identified participants. 
Similar findings were found by Karatas et al. (2007); three individuals were identified 
with a unilateral SNHL and three other individuals with bilateral SNHL. Overall, 
evidence confirms that a bilateral SNHL is more likely to manifest; however, an 
audiologist should anticipate the possibility of identifying either a unilateral or 
bilateral SNHL caused by the autoimmune response related to SLE.  
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Symmetry 
 The symmetry of a bilateral hearing loss attributed to SLE should be 
considered. Published literature has focused on the identification of the frequencies 
impacted and provides only a limited amount of information regarding whether the 
hearing losses were symmetrical or asymmetrical. Early findings from Sperling et al. 
(1996) concluded that asymmetric hearing losses were prevalent in lupus patients. 
Others have found contrasting results to Sperling et al. (1996). The 20 patients 
identified by Roverano et al. (2006) with a SNHL loss were all symmetrical. 
Additionally, both standard audiometric testing and auditory brainstem response 
(ABR) testing by Maciazczyk et al. (2011) identified symmetrical bilateral losses in 
the recruited participant group. From this analysis, it appears that there is greater 
prevalence of symmetrical SNHL than asymmetrical SNHL in systemic lupus patients.  
Hearing Loss Severity  
 The following parameters of hearing loss associated with SLE have been 
identified: frequency and symmetry. The degree or severity of disease activity is an 
additional feature that is utilized to anticipate a hearing loss. In the previous study, 
Maciazczyk et al. (2011) evaluated the patients according to the severity of renal 
conditions, central nervous system conditions, and antibody levels, all of which are 
influenced by SLE severity. An audiometric evaluation consisting of pure-tone 
audiometry, speech recognition testing, word recognition testing, tympanometry, and 
auditory brainstem response testing was completed and results were compared to those 
of a control group consisting of age-matched participants with normal hearing 
sensitivity and no health conditions. The degree of the hearing loss and the severity of 
the SLE were found not to be correlated. Therefore, the researchers established that 
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greater organ involvement does not necessarily mean that a greater degree of hearing 
loss will manifest.   
 Roverano et al. (2006) reported similar outcomes. The Systemic Lupus 
Erythematosus Disease Activity Index was administered prior to completing 
audiometric measures in order to quantify the disease activity of each patient. Of the 
21 patients with a hearing loss, 11 reported little disease activity while the remaining 
10 described persistent activity, experiencing a flare-up, or impairment caused by the 
disease activity. Roverano et al. (2006) concluded that there was not a correlation 
between disease activity and the presence of a hearing loss.  
 Numerous characteristics are associated with SNHL loss due to SLE. While 
there is variability in the outcomes, audiologists can anticipate a number of features 
yet still be vigilant of the possible dissimilarities. Bilateral, symmetrical, high-
frequency sensorineural losses are likely to be the most common audiometric 
configuration. However, the audiologist should be aware of disease involvement if a 
loss in the mid or lower frequencies has been identified. Prior to the evaluation, the 
audiologist should ask the patient when the first symptoms of the disease were 
apparent. This is a useful additional piece of information that can be used by the 
audiologist. This interpretation of the published work suggests that there is a common 
model of hearing loss associated with SLE; however, audiologists should also be 
conscientious of the diverse audiometric features that can occur.  
Vertigo 
 Over the years, the connection between SLE and vertigo has become more 
apparent. Karatas et al. (2007), with the use of electronystagmography (ENG), found 
that out of the 19 patients reporting audiovestibular symptoms, eight of this subset 
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experienced symptoms of vertigo. The ENG testing established that 50% of the SLE 
patients had abnormal vestibular responses. Further evaluation identified the following 
abnormalities: gaze nystagmus, abnormal optokinetic performance, and positional 
nystagmus. Eleven of these 19 patients had poor caloric responses.  
 During this same period of time, Gomides et al. (2007), with the use of the 
Systemic Lupus Erythematosus Disease Activity Index, identified that 31.1% of their 
participants reported vertigo. This finding is significantly greater than the reports of 
vertigo from the control group (6.7%). Batuecas-Caletrío et al. (2013) recruited 89 
SLE patients and determined that a subset of this population is susceptible to 
vestibular disorders. Peripheral vertigo was identified in eight patients and benign 
paroxysmal positional vertigo in one patient.  
 Kariya et al. (2016) evaluated the pathogenesis of vertigo associate with SLE. 
Fifteen temporal bones from patients with SLE were used to examine the integrity of 
the hair cells within the vestibular system, specifically in the saccular macula, the 
utricular macula, as well as within the cristae. When compared to the control group, 
there was a significant decrease in the number of type I hair cells, afferent cells, in all 
of the vestibular structures mentioned. However, there was not a significant difference 
when type II hair cells, or efferent cells, were evaluated.  
Tinnitus 
 The SLE patients have also reported the presence of tinnitus. When surveys 
were administered to participants, Maciazczyk et al. (2011) determined that 40% 
reported tinnitus. Furthermore, Karatas et al. (2007) identified nine individuals with 
tinnitus out of the 19 patients reporting audiovestibular involvement. While the reports 
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of tinnitus vary by patient, these studies indicate an association between tinnitus and 
SLE.   
Identification of Autoimmune-Related Hearing Loss 
 
 Standardized conventional pure-tone audiometry has a role in identifying the 
degree and type of hearing loss in SLE patients; however, additional diagnostic 
measures can be utilized to identify and monitor the progression of the hearing loss. 
This includes the administration of OAEs and extended high-frequency audiometry 
(EHFA). The following section will review the components of the standard 
audiometric battery as well as OAEs and high-frequency audiometry; all of which will 
aid the audiologist in the identification of secondary autoimmune inner ear disease due 
to SLE.  
Audiometric Test Battery  
 Otoscopy, immittance audiometry, pure-tone audiometry, and speech 
recognition testing comprise the collection of tests that are administered within a 
standard hearing evaluation. The purpose of otoscopy is to evaluate the condition of 
the outer ear and identify foreign bodies or pathologies. Immittance audiometry 
evaluates the integrity of the middle ear structures and measures the efficacy of how 
sound is transmitted within the outer and middle ear regions. Together, otoscopy and 
immittance audiometry provide early indications of possible conductive components. 
 Pure-tone audiometry is the subjective measurement of the transmission of 
tones from the outer ear to the cortical pathways leading to the auditory cortex. 
Auditory thresholds from 250 Hz to 8000 Hz are determined with the use of air-
conduction testing, using insert or supra-aural headphones, and bone-conduction 
testing, with the utilization of a bone oscillator placed on the mastoid or forehead. If 
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thresholds are found outside of normal limits in an adult, exceeding a 20 dB hearing 
level, and conductive components are not apparent, this is evident of a pathology or 
condition within the inner ear or the central nervous system. Electrophysiological 
testing, such as ABR and electrocochleography, is completed to identify the 
functionality of these anatomical regions but is not part of the standard audiometric 
test battery.  
Use of Otoacoustic Emissions 
 Numerous researchers have identified autoimmune-related hearing loss with 
the utilization of transient evoked and distortion production OAEs. The purpose of 
OAE testing is to evaluate the functionality and motility of the cochlear outer hair 
cells (OHC). The anatomy of the organ of Corti permits the OHCs to move in a 
fashion that results in additional movement of nearby anatomical structures, such as at 
the basilar membrane, and is referred to as the electromotile response. This response 
that is elicited from an external sound source causes a wave of energy to travel in a 
distal direction from the cochlea and towards the external auditory meatus. Due to the 
tonotopic organization of the cochlea, frequency specific information can be obtained 
by using a stimulus tone located near the target frequency on the basilar membrane 
(Glattke & Robinette, 2007).  
 The OAE testing is comprised of presenting a stimulus using a probe placed in 
the ear canal. During the presentation of the stimulus in distortion product otoacoustic 
emissions (DPOAE) testing, the miniscule cochlear response is measured 
simultaneously. Individuals with normal hearing sensitivity have strong responses 
indicating normal OHC motility; presence of the electrical potential of the stria 
vascularis, the structure that supplies nutrients to the OHCs, and the absence of any 
21 
 
conductive component that prohibits the transmission of auditory signals leading to 
and from the cochlea. Abnormal or absent responses may indicate damage to the 
OHCs, damage to the stria vascularis, or a conductive component such as impacted 
cerumen and otitis media (Glattke & Robinette, 2007). Two types of OAEs have been 
used to monitor autoimmune inner ear disease: TEOAEs and DPOAEs.  
 The frequencies that had decreased OAE responses varied according to the 
type of autoimmune disease. Despite this variance, high frequencies were found to be 
more susceptible. Karabulut et al. (2010) completed a study comparing 30 subjects 
without SLE to 26 patients with SLE. The researchers concluded that patients with 
SLE may have absent DPOAEs for frequencies at 750 and 6000 Hz and absent 
TEOAEs at 2000 and 3000 Hz.  
 Larsen et al. (2015) obtained DPOAEs on rates with cochlear damage due to 
induced autoimmune involvement. The researchers completed DPOAEs on rats with 
cochlear damage due to autoimmune involvement. Absent responses were identified 
from 2000 to 63000 Hz. Therefore, in a controlled setting, Larsen et al. demonstrated 
that high-frequency regions of the cochlea were more susceptible to auditory damage 
and impaired DPOAEs.   
 Use of OAEs may be able to provide audiologists with the initial identification 
of auditory damage attributable to an abnormal autoimmune response in the cochlea. 
Botelho et al. (2014) recommended that the use of distortion product OAEs would be 
advantageous for monitoring early progression of the hearing loss.  This method of 
testing could be especially beneficial for audiologists who are providing care to a high 
case load of patients. The use of OAEs provides a swift measurement of cochlear 
damage in relation to the functionality of the OHCs. 
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Use of Extended High-Frequency 
Audiometry 
 The advantage of determining thresholds at frequencies above the conventional 
pure-tone test frequencies (250 – 8000 Hz) includes early identification of a hearing 
loss, especially with patients susceptible to ototoxic medications or with a history of 
noise exposure (Valiente et al., 2016). The extended high frequencies include 9000 to 
20000 Hz. Karabulut et al. (2010) published their findings after completing thorough 
audiometric testing with 26 SLE patients matched with 30 healthy participants. The 
objective of this study was to fill in the gap in the literature pertaining to the 
knowledge of the mechanisms causing hearing loss in patients with SLE. Measures 
included EHFA (250, 500, 1000, 2000, 4000, 6000, 8000, 10000, 12000, 14000, and 
16000 Hz), which was accompanied by DPOAE and TEOAE testing. When the SLE 
group and control group were compared according to pure-tone audiometry testing, 
significant differences between the SLE and control groups were identified at 250, 
500, 1000, 2000, 10000, and 12000 Hz (p < 0.05 significance). These findings indicate 
that a SNHL can extend into the higher frequencies, specifically to 10000 and 12000 
Hz.  
 Lasso de la Vega et al. (2017) measured pure-tone thresholds from 125 to 8000 
Hz, followed by EHFA pure-tone audiometry (9000, 10000, 11200, 12500, 14000, 
16000, and 18000 Hz. Presbycusis was controlled for by recruiting younger patients 
(the mean age of the 55 participants was 41.5 years). Hearing thresholds obtained at 
125-8000 Hz were compared to the EHFA that assessed 8000 to 18000 Hz. Findings 
revealed the presence of a SNHL between 8000 Hz and 18000 Hz in 70% of the 
patients. Significant threshold differences were identified at 10000, 11200, 12500, 
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16000, and 18000 Hz when the SLE and healthy participants were compared. Overall, 
it was determined that an extended high-frequency loss from 8,000 Hz to 18000 Hz 
was 33.6 times greater to be identified than a hearing loss that can be identified with 
traditional pure-tone audiometry testing. Lasso de la Vega et al. concluded their results 
with the following statement: 
These results suggest and recommend that audiological assessment should be 
done not only with [pure tone average] but also [extended high-frequency 
audiometry] in patients with SLE in order to diagnose a possible subclinical 
hearing loss and modify the ongoing treatment or add a therapy to prevent a 
possible progression of hearing loss. (p. 165) 
 
 Hearing loss associated with autoimmune inner ear disease hearing loss should 
be monitored for a number of reasons. The first is to monitor the progression of the 
hearing loss over time as disease duration increases and in collaboration with 
physicians, select appropriate therapeutic options. Moreover, SLE patients should be 
monitored due to the risk of ototoxic effects of the treatment medications, such as the 
antimalarial drug hydroxychloroquine. The use of EHFA and OAEs allows the 
audiologist to document sub-clinical auditory damage as well as identify the early 
onset of the SNHL.  
 A suggested audiometric test battery for SLE patients needs to include the 
standardized pure-tone air and bone audiometry, impedance audiometry, speech and 
word recognition tests, as well as OAEs and EHFA. The addition of the OAEs and 
EHFA at the initial evaluation would establish baseline thresholds that could be used 
as a reference during the monitoring process. These measures may provide early 
warning signs of threshold changes related to the autoimmune disease.  
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Ototoxic Medications 
 Multiple medications are prescribed to patients with SLE, and medications 
may be added depending on the secondary symptoms that accompany the disease. 
Synthetic antimalarial medications such as hydroxychloroquine (Plaquenil) and 
chloroquine (Aralen) are the primary drugs used to control the symptoms of SLE. 
Patients are counseled to take the medication for the remainder of their lives. These 
medications are also utilized in the treatment of rheumatoid arthritis and other 
connective tissue disorders (Bortoli & Santiago, 2007). What is concerning is the 
chemical relationship of these medications to quinine; both hydroxychloroquine and 
chloroquine are subtypes of quinine (Rynes & Park, 1993). Exposure to quinine, also 
used in the treatment of malaria, has been reported in patients diagnosed with SNHL, 
vertigo, and tinnitus (Jung et al., 1993). The ototoxic effects of quinine have been 
observed at the spiral ganglion neurons within the cochlea may also affect the mobility 
of the outer hair cells resulting in a decreased electromotile response (Zheng et al., 
2001). At this time, toxic effects of quinine on the vestibular system have not been 
substantiated. 
 One case of accidental overdose of hydroxychloroquine resulted in permanent 
auditory and vestibular symptoms. Chansky and Werth (2017) reported an incident in 
which a patient experienced bilateral tinnitus and ataxia as well as symptoms of 
numbness in her arms and legs. Changes in hearing sensitivity were not noted.  
 The outcomes of several studies suggest that patients taking 
hydroxychloroquine and chloroquine can develop a sensorineural hearing loss. The 
earliest reported study was by Johansen and Gran (1998) who described the 
development of a severe SNHL loss in two SLE patients who had undergone years of 
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hydroxychloroquine drug therapy. Seckin et al. (2000) reported findings in which a 
woman developed a SNHL after five months of hydroxychloroquine treatment for 
rheumatoid arthritis. When hydroxychloroquine was prescribed as a drug therapy for a 
patient with HIV, a moderate-severe sensorineural hearing loss developed (Khalili et 
al., 2014). What is unique for this specific case is that when hydroxychloroquine 
exposure was ceased, audiometric testing revealed improved thresholds and indicated 
that for HIV patients, hearing loss may be reversible. While not commonly reported, 
physicians should be aware of the potential ototoxicity of the prescribed medication, 
especially due to the long-term treatment course.  
 The SLE patients are susceptible to SNHL due to progression of autoimmune 
inner ear disease, as well as the potential ototoxicity from antimalarial medications 
used to control the progression of SLE. This review suggests that audiologists should 
complete a thorough case history of SLE patients, identifying whether patients have 
been prescribed this class of medications and if so, the duration of the exposure. With 
the possible association of hydroxychloroquine and chloroquine to ototoxicity, 
audiologists should implement auditory and vestibular evaluations to monitor any 
changes in hearing sensitivity or balance  
Resources and Support Groups 
 The invasive nature of SLE in addition to multiple secondary disorders can be 
tolling on the patient. Support groups for SLE patients are available in multiple 
formats and offered across the United States. The Lupus Foundation of America has 
17 chapters located in numerous states. Another national group is Molly’s Fund 
Fighting Lupus which has chapters established in Oregon, Wyoming, Tennessee, and 
Massachusetts. Innumerable support groups are accessible online as well via websites 
26 
 
or Facebook. Lupus Warriors, a Facebook group, currently has 11,000 members and 
serves as a location to ask lupus-related questions and ask for support throughout 
difficult times. The website group Daily Strength currently has 874 members. The 
individuals are comprised of SLE patients and family members of those with SLE.  
 Partnerships have been established to advance lupus research, such as the 
Lupus Research Alliance. Located in New York City, the Lupus Research Institute 
promotes opportunities for SLE patients to participant in ongoing research with a 
focus on preventing, treating, and curing SLE. In June 2017, the Lupus Research 
Alliance established an advocacy group that successfully supported the expansion of 
funds for medical research on SLE. The opportunity to support other SLE patients and 
participants in ongoing research has formed a community for both patients and family 
members impacted by the disease. These resources assist patients recently diagnosed 
with hearing loss and provide information about other patients with similar 
experiences.  
Future Research 
 Future research should be qualitative in design in order gain insight about the 
experiences of practicing audiologists caring for SLE patients, as each case may be 
different due to the nature of the disease. Investigation should be completed in order to 
determine what resources audiologists rely on. Furthermore, with the rise of studies 
evaluating the details and relationship between hearing loss and SLE, there is the 
question of whether this information has been integrated into graduate school courses 
and classes developed for audiologists to earn continuing education units. The current 
study answered these questions in a qualitative manner. 
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CHAPTER III 
 
METHODS 
 
 The purpose of this chapter is to outline the steps of survey administration and 
data collection. The survey was constructed to describe the knowledge, attitudes, and 
practices of audiologists and audiology graduate students caring for patients with a 
hearing loss induced by systemic lupus erythematosus (SLE). This qualitative survey 
was intended to accumulate statements and information regarding the provision of 
audiological care for SLE patients and further inform best clinical practice in the 
future. Appendix A includes the Institutional Review Board approval of the survey 
and the overall project from the University of Northern Colorado. 
Development of the Survey Instrument 
 Four sections made up the survey: demographics, knowledge, attitudes, and 
practices. The demographic questions developed for the audiologists inquired on the 
period of time the participant had practiced in audiology, what setting in which the 
participant was currently practicing in, and which state in the United States they were 
currently located. For graduate students, demographic questions included the number 
of years completed within the program, the number of years of supervised clinical 
experience accumulated, whether they were currently working at an internship or 
externship location, and the location of the educational institution.  
 Prior to the administration of the electronic survey, a small pilot study was 
completed to ensure that the survey was functional and that the questions were clearly 
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understood. The necessary modifications to questions were made after the trial period 
and before electronic links were distributed to participants in the main study.  
Participants 
 Two populations were invited to complete the survey (see Appendix B): 
graduate students enrolled in an accredited doctor of audiology graduate program or a 
doctor of philosophy graduate program in audiology, and licensed audiologists who 
were currently practicing. Licensed audiologists were included who were employed 
within a medical setting, speech and hearing clinic, corporate audiology group 
practice, otolaryngologist office, government patient care facility (such as Veterans 
Affairs or Indian Health Services), hospital, military setting, or private practice setting. 
Additional inclusion criteria considered whether the practicing audiologist provided 
direct patient care for an adult population. Audiologists were excluded who did not 
have experience seeing patients, were retired, or who were working in the educational 
field. Audiology graduate students had to be enrolled in an institution within the 
United States and the practicing audiologists must have been licensed in the United 
States.  
Survey Instrument 
 The electronic survey was developed using the Qualtrics (Smith, 2005) 
software. A number of strengths of this software include permitting the survey 
developer to coordinate the order in which the questions were sequenced based upon 
the responses submitted by the survey-taker. For instance, the question, “What best 
describes your current role in audiology?” served to identify the two groups of 
participants; practicing audiologists and graduate students. In relation to the response 
provided, the survey used skip logic to guide students to specific questions relating to 
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their academic experience, while certified practicing audiologists were directed to 
questions regarding their clinical experience.  
 Fifty-three questions were developed and divided into four sections: 
Demographics, Knowledge of Systemic Lupus Erythematosus, Attitudes Towards 
Systemic Lupus Erythematosus, and Practices in the Audiological Care of Patients 
with Systemic Lupus Erythematosus. Within the demographics portion, questions 
were presented according to whether the participant identified as a graduate student or 
a practicing audiologist. This was determined with the first question: “What best 
describes your current role in the field of audiology?” One purpose of the 
demographics section was to identify survey-takers who did not have a role in 
audiology and practicing audiologists who had not worked in a medical setting; both 
groups were directed to the end of the survey. Within the demographics portion, there 
were five questions for graduate students to answer and eight, at most, for practicing 
audiologists.  
 Sixteen questions made up the Knowledge of Systemic Lupus Erythematosus 
section that both participant groups completed. A total of 13 questions were formatted 
as forced-choice; three of these questions included text-boxes for the survey-taker to 
elaborate on the response. Furthermore, two questions required that the participant to 
select all of the options that applied to the statement presented.  
 The Attitudes Towards Systemic Lupus Erythematosus segment required 
answers to nine questions. The section began with a true/false question regarding the 
importance of referrals to otolaryngologists for SLE patients. This was then followed 
by two questions regarding whether additional tests procedures should be included in 
the test battery and which evaluations, from a provided list, should be included. A total 
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of eight statements and questions were presented that required the survey-taker to use 
a sliding scale to report an answer. Seven of these questions utilized a scale of strongly 
disagree to strongly agree and one question that utilized a not confident to confident 
scale.  
 The final section, Practices Associated with Systemic Lupus Erythematosus 
was composed of a collection of questions regarding whether the participant had cared 
for a patient with SLE, the referral process and what other professionals were typically 
contacted, whether the clinic in which the participant currently practiced had a 
protocol for these patients or other autoimmune disease patients, and open-ended 
questions about the development of a protocol for working with SLE patients.  
Sampling Methods 
 Survey promotion to both audiologists and audiology graduate students was 
electronic and accessible through a number of resources. One method was to post a 
brief description and survey link on audiology-related Facebook groups. These groups 
included Audiology Antics and Anecdotes For All Hearing Professionals, SOUNDing 
Board Hearing Healthcare Professionals, Academy of Doctors of Audiology, and 
Student Academy of Doctors of Audiology. All of these Facebook pages have 
practicing audiologists and audiology graduate student followers.  
 The survey was also promoted in the E-Newsletter SAAy Anything that is 
published every month. This allowed the survey to be distributed directly to graduate 
students.  
 Furthermore, the use of snowball sampling was used. After the audiologist or 
the graduate student completed the survey, a final note encouraged the survey-taker to 
share the survey link to colleagues and peers in order to promote snowball sampling. 
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Qualtrics (Smith, 2005) was programmed to only accept one survey response from an 
Internet protocol address to partially control for multiple responses to the same survey.  
Descriptive Analysis 
 Qualtrics was utilized to collect and analyze the data. This software permits a 
researcher to design an original survey tool as well as the ability to summarize and 
collate the results collected from the survey. Question development can range in 
format, including multiple-choice selections, text-box options, and a gap analysis 
style. In order to determine the SLE knowledge of both graduate students and 
practicing audiologists, the average number of questions correctly answered according 
to each participant group was calculated. For the attitudes portion, the multiple-choice 
questions were formatted to allow respondents to rate their answer from strongly 
disagree to strongly agree. The scores were averaged within each participant group 
and compared descriptively.  
 The goal of this analysis was to allow an interpretation of the results for both 
closed-choice questions and open-ended questions. The intention was to allow both 
respondent groups to provide details of particular experiences in caring for these 
patients and to gauge the degree of confidence and knowledge in caring for this SLE 
patient population 
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CHAPTER IV 
 
RESULTS 
 
Respondent Characteristics 
 
 A total of 133 individuals responded to the survey; 32 respondents identified as 
licensed audiologists and 86 as graduate students. The remaining 12 responses were 
false starts in which the survey was started but the first question, asking if the 
respondent was a licensed audiologist or graduate student, was not answered. Initial 
survey-based exclusion criteria in the licensed audiologist section included both 
whether the respondent had provided direct patient care after receiving their degree 
and if the individual was currently practicing in the United States. In the end, two 
respondents were excluded for not having experience with direct patient care. One 
observation made when implementing this exclusion criteria was that when the 
graduate students who answered no to the question “Have you read or heard about the 
autoimmune disease systemic lupus erythematosus?” many of them (n = 19) stopped 
the survey shortly afterwards, and they may not have realized the survey would still 
record their responses to other questions.  
 Therefore, another consideration for analysis included the extent to which the 
survey was submitted with full completion. This chapter is composed of the 
information collected from the surveys in which the respondents answered all of the 
questions: 47 questions for licensed audiologists and 43 questions for graduate 
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students. This resulted in a total of 24 licensed audiologist and 53 graduate student 
surveys (n = 77) used for analysis.  
Demographics of Graduate 
Students 
 
 The majority of respondents (n = 53) who identified as graduate students 
reported that they were between their third and fourth year of the audiology doctoral 
program (33.96%, n = 18), followed by those in between the second and third year 
(24.53%, n = 13). Two to three years of clinical experience was the greatest amount 
(5.85%, n = 19) reported, followed by three to four years (24.53%, n = 13). See Table 
1 for additional training and experience outcomes. Furthermore, when asked whether 
the externship had been started, 52.82% (n = 28) of the respondents had not started 
this phase of the graduate program, while 47.17% (n = 25) reportedly were at an 
externship site. This is considering the fact that some graduate students may start their 
clinical experience at a different time compared to students enrolled in other graduate 
programs.  
Students were primarily in programs located in Colorado, South Dakota, and 
Wisconsin. Other locations included North Carolina, Oregon, and Texas. Overall, the 
respondents were completing programs in the Midwestern United States. 
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Table 1 
 
Program Status of Graduate Student Respondents  
 
 
Status 
 
 
<1 yr 
% 
 
 
1-<2 yrs 
% 
 
2-< yrs 
% 
 
3-<4 yrs 
% 
 
4-<5 yrs 
% 
 
5-<6 yrs 
% 
 
Yr in 
program 
(n = 53) 
 
 
9.43 
(n = 5) 
 
16.98 
(n = 9) 
 
24.53 
(n = 13) 
 
33.96 
(n = 18) 
 
13.21 
(n = 7) 
 
1.89 
(n = 1) 
Number of 
clinical yrs 
(n = 53) 
 
13.21 
(n = 7) 
15.09 
(n = 8) 
35.85 
(n = 19) 
24.53 
(n = 13) 
9.43 
(n = 5) 
1.89 
(n = 1) 
 
 
 
 
Demographics of Licensed Audiologists 
 
 When posed with the question of terminal degree, 20 individuals (83.33%) 
reported to have a doctoral degree in audiology. Two individuals identified as having a 
master’s of science (8.33%). Other degrees noted were one doctor of philosophy 
(4.16%) and one doctor of education (4.16%). 
 The location of the licensed audiologists was predominately Colorado 
(33.33%, n = 8) followed by Oregon (12.5%, n = 3) and North Carolina (12.5%, n = 
3). Other locations to note were Texas (8.33%, n = 2), Minnesota (8.33%, n = 2), and 
Alabama (4.17%, n = 1). Pennsylvania, Idaho, Utah, Kentucky, and Maryland were 
also included with one individual from each.   
 Licensed audiology respondents identified predominately as having practiced 
less than five years (46%, n = 11) followed by audiologists who have practiced for 21 
to 30 years (13%, n = 5). The responses for the number of years in a medical setting 
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were mainly under five years (52%, n = 12) and six to 10 years (26%, n = 6). When 
asked whether the individual had practiced in a medical setting, most licensed 
audiologists had this experience when they took the survey (95.83%, n = 23). All 24 
respondents reported that they had provided some form of direct patient care after 
graduation. See Figure 1 for further details. 
The most common current audiology practice settings included direct patient 
care in an ear, nose, and throat office (30%, n = 8) and private practice (22%, n = 6). 
This question was formatted for the respondent to select all the options that currently 
applied in the case that the respondent was working multiple part-time positions. One 
individual selected other and elaborated that they were employed at a nursing facility 
(4.17%) (see Figure 2). 
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Figure 1 
 
Number of Cumulative Years of Practice and Number of Years in a Medical Setting 
Reported by AudiologistRrespondents 
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Figure 2 
 
Practice Setting of the Licensed Audiologists 
 
 
 
 
 
 
Knowledge Outcomes 
 
The remainder of this chapter is divided into three sections: knowledge, 
attitudes, and practices. Both audiologists and graduate student responses are 
separately integrated into the subsequent tables and figures. The knowledge section 
begins with questions regarding pre-existing knowledge of systemic lupus 
erythematosus (SLE) of both groups and followed by pre-existing knowledge of SLE 
and hearing loss. Outcomes of questions concentrating on clinical audiologic features 
of SLE and hearing loss are included at the end. 
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Pre-existing Knowledge of Systemic 
Lupus Erythematosus 
 
 When posed with the question regarding whether students and audiologists 
were aware of SLE and SLE associated with hearing loss, more students reported 
awareness of SLE associated with hearing loss over SLE itself. In comparison, the 20 
audiologists (83.00%) who identified as having an awareness of SLE were also aware 
of the diseases’ association with hearing loss. The majority of both respondent groups 
had some degree of awareness regarding an association of SLE and hearing loss. A 
summary of the details are provided in Table 2. 
 
Table 2 
 
Awareness of Systemic Lupus Erythematosus (SLE) and Awareness of SLE Related 
Hearing Loss by Graduate Students and Audiologists 
 
 
Knowledge of SLE 
 
Graduate students 
(n = 53) 
% 
 
 
Licensed audiologists 
(n = 24) 
% 
 
Aware of SLE 
 
 
60.38 
(n = 32) 
 
83.00 
(n = 20) 
 
Awareness of SLE and 
hearing loss 
 
69.81 
(n = 37) 
83.00 
(n = 20) 
 
 
 
 
 After establishing whether the respondents had this pre-existing knowledge, 
those who were knowledgeable of SLE were asked where they first learned of the 
disease. As a result, the pool of affirmative responses (n = 52) was smaller than the 
total number of respondents (n = 77). A total of 32 graduate students and 20 licensed 
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audiologists were included and responses were spread across all sources of 
information. Graduate students primarily had a personal relationship as their source of 
initial knowledge at 21.88% (n = 7). Audiologists, on the other hand, initially learned 
of SLE from providing care to a patient with 15% (n = 3) or from another health care 
professional at 15% (n = 3). Graduate students also reported learning of SLE in high 
school with 3.13% (n = 1), and one respondent reported having an autoimmune 
disorder related to SLE at 3.13% (n = 1). For the licensed audiologists, one was 
diagnosed with SLE (5%), another needed SLE to be ruled out as their own personal 
medical condition (5%), and the third from their mother (5%); it was not noted 
whether the mother was diagnosed with SLE. A summary is provided in Table 3. 
For knowledge of hearing loss related to SLE, this was again directed to the 
separated pool of 52 respondents. A total of 35.85% (n = 19) graduate students 
reportedly learned of the association from a graduate school course. These courses 
included standard medical audiology classes, such as medical aspects, pathologies of 
hearing, and auditory and vestibular pathologies. One student (3.13%) reportedly had 
a pediatric audiology class that covered this topic while another student (3.13%) had a 
clinical problem-solving class that included SLE. A similiar outcome was also evident 
with audiologists. Graduate school courses that were not the standard medical 
audiology class included a case study in a practicum staffing course (see Table 4). 
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Table 3 
  
Sources of Systemic Lupus Erythematosus (SLE) Information Identified by Graduate 
Students and Audiologists  
 
 
Source of information 
 
Graduate students 
(n = 32) 
% 
 
 
Audiologists 
(n = 20) 
% 
 
Total responses 
(n = 52) 
% 
 
Electronic media 
 
6.25 
(n = 2) 
 
0.00 
(n = 0) 
 
3.85 
(n = 2) 
 
From an audiology colleague 6.25 
(n = 2) 
10.00 
(n = 2) 
7.69 
(n = 4) 
 
From another health care 
professional 
9.38 
(n = 3) 
15.00 
(n = 3) 
11.54 
(n = 6) 
 
Graduate school course 18.75 
(n = 6) 
10.00 
(n = 2) 
15.39 
(n = 8) 
 
Peer reviewed journal 3.13 
(n = 1) 
0.00 
(n = 0) 
1.92 
( n = 1) 
 
Personal relationship 21. 88 
(n = 7) 
0.25 
(n = 5) 
23.07 
(n = 12) 
 
Print, books, newspaper, 
magazine 
3.13 
(n = 1) 
0.00 
(n = 0) 
1.92 
(n =1 ) 
 
Providing care to a patient 
with SLE 
3.13 
(n = 1) 
15.00 
(n = 3) 
7.69 
(n = 4) 
 
Television 18.75 
(n = 6) 
10.00 
(n = 2) 
15.39 
(n = 8) 
 
Other 9.38 
(n = 3) 
15.00 
(n = 3) 
11.54 
(n = 6) 
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Table 4 
How Respondents were First Aware of the Relationship of Hearing Loss to Systemic 
Lupus Erythematosus (SLE) 
 
 
Responses 
 
Graduate students 
(n = 53) 
% 
 
 
Audiologists 
(n = 24) 
% 
 
Total 
(n = 77) 
% 
 
 
Audiologic care to patient 
with SLE 
 
 
1.89 
(n = 1) 
 
16.67 
(n = 4) 
 
6.49 
(n = 5) 
Audiology colleague 
 
 
11.32 
(n = 6) 
8.33 
(n = 2) 
10.39 
(n = 8) 
Electronic media/internet 
source 
 
5.66 
(n = 3) 
4.17 
(n = 1) 
5.19 
(n = 5) 
Graduate school course 
  
 
35.85 
(n = 19) 
20.83 
(n = 5) 
31.17 
(n = 24) 
Healthcare professional  
 
 
3.77% 
(n=2) 
4.17% 
(n=1) 
3.90% 
(n=3) 
Peer reviewed journal 
 
 
1.89 
(n = 1) 
12.5 
(n = 3) 
5.19 
(n = 4) 
Personal relationship 
 
 
1.89 
(n = 1) 
4.17 
(n = 1) 
2.60 
(n = 2) 
Print, books, newspapers, 
magazine 
 
0.00 
(n = 0) 
0.00 
(n = 0) 
0.00 
(n = 0) 
Television 1.89 
(n = 1) 
4.17 
(n = 1) 
2.60 
(n = 2) 
 
Were not aware 
 
 
30.19 
(n = 16) 
16.67 
(n = 4) 
25.97 
(n = 20) 
Other  5.66 
(n = 3) 
8.33 
(n = 2) 
6.49 
(n = 5) 
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 Figure 3 summarizes the sub-set of responses for when respondents first 
became aware of SLE. Graduate students were generally aware of SLE for less than 
five years as a predominant answer (63%, n = 20) which coincides with their years in 
the degree program. For audiologists, 25% (n = 5) reported that it had been six to 10 
years since they had first become aware of SLE and 25% (n = 5) selected that they 
were unsure of the time frame.  
Knowledge of Audiologic 
Symptoms 
 
 The following section outlines how graduate students and licensed audiologists 
were able to answer questions specifically regarding audiologic symptoms observed in 
patients with SLE. Due to a survey design error that permitted the respondent to skip 
the question, two questions were removed due to the high rate of skipped responses. 
These questions included asking what the greatest degree of hearing loss tends to be in 
patients with SLE and the question on whether the hearing loss tends to be progressive 
or stable. Eight knowledge questions remained afterwards; Table 5 provides a 
summary of these results in the context of correctness based on peer-reviewed 
evidence in the literature (Chapter II). 
 
 
 
 
 
 
 
43 
 
Figure 3 
 
How Long Ago were Graduate Students and Licensed Audiologists First Aware of 
Systemic Lupus Erythematosus (SLE) 
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Table 5 
 
Number of Correct Responses between Graduate Students and Licensed Audiologists 
 
 
Response 
 
% correct 
 
  
Graduate students 
(n = 46) 
 
Licensed audiologists 
(n = 24) 
 
 
What type of hearing loss is 
commonly associated with hearing 
loss from SLE autoimmune 
responses? 
 
For patients with SLE, does the 
hearing loss tend to be bilateral or 
unilateral? 
 
Do you believe that the duration of 
SLE and the degree of hearing loss 
are correlated? (e.g., the longer a 
person has had SLE, the poorer the 
hearing). 
 
Can patients with SLE experience 
vertigo that is attributed to the 
presence of the autoimmune disease? 
 
SLE is thought to arise in patients 
from which of the following factors: 
 
The following medications are used 
in the treatment of SLE. Based on 
your knowledge, which ones can be 
ototoxic, if any? Selected choice 
 
 
86.79 
(n = 46) 
 
 
 
41.51 
(n = 22) 
 
 
71.70 
(n = 38) 
 
 
 
 
75.47 
(n = 40) 
 
 
77.36 
(n = 41) 
 
41.51 
(n = 22) 
 
 
87.5 
(n = 21) 
 
 
 
37.5 
(n = 9) 
 
 
62.5 
(n = 15) 
 
 
 
 
70.83 
(n = 17) 
 
 
66.67 
(n = 16) 
 
37.5 
(n = 9) 
 
 
 
 
 
 
Note. SLE = systemic lupus erythematosus. 
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Attitudes of Licensed Audiologists and 
Audiology Graduate Students 
 Both groups were presented the question on whether additional audiological 
tests should be added to the standard audiometric test battery. This is specific to the 
situation in which a patient with SLE is being provided audiologic care. The majority 
of both graduate students and audiologists (84.42%, n = 65) held the opinion that 
additional tests should be included: 92.45% (n = 48) with graduate students and 
70.83% (n = 17) with licensed audiologists.  
Respondents were allowed to select multiple tests. Evaluation with an extended 
high frequency audiometry (EHFA) and distortion product otoacoustic emissions 
(DPOAEs), were common selections within both groups; however, a total of 28 
graduate students (58.33%) selected EHFA more often than the eight audiologists 
(47.09%). See Table 6 for the number of total responses associated with each test. 
Figure 4 compares graduate student and audiologist responses from the Likert 
scale questions regarding respondent attitudes. Neither graduate students nor 
audiologist feel confident in their knowledge of SLE or their ability to counsel patients 
with SLE. Audiologists and graduate students were neutral regarding whether they had 
the resources to allow them to provide audiologic care to patients with SLE.   
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Table 6  
 
Tests that Should be Added to the Standard Audiometric Battery for Patients Being 
Monitored for Systemic Lupus Erythematosus (SLE) 
 
 
Test 
 
 
Graduate students 
(n = 48) 
% 
 
Audiologists 
(n = 17) 
% 
 
Total 
(n = 65) 
% 
 
 
Acoustic reflex threshold 
 
54.17 
(n = 26) 
 
58.82 
(n = 10) 
 
55.38 
(n = 36) 
 
Acoustic reflex decay 22.92 
(n = 11) 
23.53 
(n = 4) 
23.08 
(n = 15) 
 
APD Testing 
 
2.08 
(n = 1) 
0.00 
(n = 0) 
1.54 
(n = 1) 
 
Click ABR 
 
45.83 
(n = 22) 
29.41 
(n = 5) 
41.54 
(n = 27) 
 
DPOAEs 
 
64.58 
(n = 31) 
82.35 
(n = 14) 
69.23 
(n = 45) 
 
ECohG 
 
20.83 
(n = 10) 
17.65 
(n = 3) 
20.00 
(n = 13) 
 
Extended HFA 
 
58.33 
(n = 28) 
47.09 
(n = 8) 
55.38 
(n = 36) 
 
Extended HF DPOAEs 39.58 
(n = 19) 
23.53 
(n = 4) 
35.38 
(n = 23) 
 
Immittance testing 
 
25.00% 
(n = 12) 
11.76% 
(n = 2) 
21.54% 
(n = 14) 
 
Multi-frequency tympanometry 2.08 
(n = 1) 
0.00 
(n = 0) 
1.54 
(n = 1) 
 
Speech in noise 0.00 
(n = 0) 
11.76 
(n = 2) 
3.08 
(n = 2) 
 
TEOAEs 
 
12.50 
(n = 6) 
11.76 
(n = 2) 
12.31 
(n = 8) 
 
VEMP 
 
2.08 
(n = 1) 
0.00 
(n = 0) 
1.54 
(n = 1) 
 
VNG 
 
4.17 
(n = 2) 
0.00 
(n = 0) 
3.08 
(n = 2) 
 
Wide-band reflectance 4.17 
(n = 2) 
0.00 
(n = 0) 
3.08 
(n = 2) 
 
 
Note. APD = auditory processing disorder, ABR = auditory brainsten response, DPOAEs = distortion product optoacoustic 
emissions, ECohG = electrocochleography, HFA = high frequency audiometry, TEOAEs = transient evoked optoacoustic 
emissions, VEMP = vestibular evoked myogenic potential, VNG = videonystagmography. 
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Figure 4 
 
Comparison of Mean Likert Scores between Graduate Students and Licensed 
Audiologists. 
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Both groups felt strongly that patients with SLE should be referred to 
additional support groups and that doctor of audiology graduate students should have 
access to materials on the disease and hearing loss. Both groups generally agreed that 
patients undergoing pharmacologic treatment may fatigue easily during testing. 
Clinical Practices for Systemic Lupus 
Erythematosus Patients 
 
 The majority of both groups of respondents had not provided care to patients 
with SLE. However, 92% (n = 19) of graduate students had no experience with SLE 
patients, compared to 59% (n = 14) of audiologists. See Figure 5 for an in-depth 
representation of their experiences. 
The sub-set of respondents (n = 14) who had provided audiologic care to 
patients with SLE differed with regard to how often hearing evaluations for patients 
with SLE should be advised (see Table 7). Graduate students were equally distributed 
between annually, every 6 months, and every 3 months (25%, n = 1). The audiologists 
(70%, n = 7) were more likely to recommend annual evaluations. Twenty to 25% of 
respondents for both groups acknowledged that annual evaluations were sufficient 
unless changes in hearing were subjectively experienced by the patient. 
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Figure 5 
 
Estimated Number of Patients with Systemic Lupus Erythematosus (SLE) Who have 
been Cared for with Licensed Audiologists and Graduate Students 
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Table 7 
 
Response Summary to the Survey Question “How Often Do You Recommend Patients 
with Systemic Lupus Erythematosus to Have a Hearing Evaluation?” 
 
 
Recommendation 
 
Graduate students 
(n = 4) 
% 
 
Audiologists 
(n = 10) 
% 
 
Total 
(n = 14) 
% 
 
 
Annually 
 
25 
(n = 1) 
 
 
70 
(n = 7) 
 
57.14 
(n = 8) 
Every 6 months 25 
(n = 1) 
 
10 
(n = 1) 
14.29 
(n = 2) 
Every 3 months 25 
(n = 1) 
 
0 
(n = 0) 
7.14 
(n = 1) 
Every month 0 
(n = 0) 
 
0 
(n = 0) 
0.00 
(n = 0) 
Annually, sooner if 
changes perceived  
25 
(n = 1) 
20 
(n = 2) 
21.43 
(n = 3) 
 
 
 
 
 
Table 8 summarizes the additional tests that are given to patients with SLE. A 
total of eight respondents contributed to this portion of the survey. It should be noted 
that these audiometric tests are not widely used within the field of audiology. 
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Table 8 
 
Additional Audiometric Rests Provided to Patients with Systemic Lupus 
Erythematosus? 
 
 
Recommendation 
 
Graduate students 
(n = 2) 
 
 
Audiologists 
(n = 6) 
 
 
Total 
(n = 8) 
 
APD testing 
 
(n = 1) 
 
(n = 0) 
 
(n = 1) 
 
OAEs 
 
(n = 0) 
 
(n = 1) 
 
(n = 1) 
 
 
Speech in noise  
 
(n = 0) 
 
(n = 3) 
 
(n = 3) 
 
Tone decay 
 
(n = 1) 
 
(n = 0) 
 
(n = 1) 
 
Other 
  
   
My basic battery is PTA/PTB, speech 
thresholds/word recognition, 
DPOAEs, immittance...reflexes 
 
(n = 0) (n = 1) (n = 1) 
Decay, OAEs, ABR (n = 0) (n = 1) (n = 1) 
 
 
Note. ABR = auditory brainstem response, APD = auditory processing disorder, 
DPOAEs = distortion product optoacoustic emissions, OAEs = optoacoustic 
emissions, PTA = pure tone average, PTB = pure tone baseline. 
 
 
Patient referrals made by licensed audiologists were predominately going to 
rheumatologists (23%, n = 6), (23%, n = 4) to family practice physicians, and (12%, n 
= 4) to otolaryngologist. This was followed by an otologist referral (18%, n = 3) and 
neurology with (18%, n = 3). Two graduate students had experience with referrals; 
one referred a patient with SLE to neurology, while the other student reported making 
a referral to rheumatology (see Figure 6). 
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Figure 6 
 
Summary of Referrals to Other Specialists Made by Audiology Graduate Students and 
Audiologists 
 
 
 
 
 
 
For the respondents who stated that a referral was not made, a follow up 
question requested further detail for their response. The licensed audiologist stated that 
there was already a team of providers in place and so no referral was necessary. This 
response was also reported by one of the two graduate students. The second graduate 
student had typed in an incoherent answer into the text box.  
 Two graduate students and two licensed audiologists stated that they use a 
specific clinical protocol for patients with SLE; however, no contact information was 
offered in order to learn more about the protocols (this was a voluntary question). 
There appears to be a strong professional interest of graduate students (89.58%, n = 
43) and licensed audiologists (95.00%, n = 19) of having a clinical protocol 
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implemented for patient with SLE. This was also reflected in the question that allowed 
the respondents to select all of the resources they believed would be beneficial to have 
in the clinic followed by an SLE resource list (83.82%, n = 57). See Table 9 for further 
details. Additionally, eight respondents (11.76%), four from the graduate student 
group and four audiologists, reported having additional training or continuing 
education in SLE. 
 
Table 9 
 
Summary of Types of Information that Would be Useful to Graduate Students and 
Audiologists with Regard to Providing Audiologic Care to Patients with Systemic 
Lupus Erythematosus (SLE)  
 
 
Response 
 
Graduate students 
(n = 48) 
% 
 
Audiologists 
(n = 20) 
% 
 
Total 
(n = 68) 
% 
 
 
Clinical diagnostic and monitoring 
protocol  
 
 
89.58 
(n = 43) 
 
95.00 
(n = 19) 
 
91.18 
(n = 62) 
List of interdisciplinary team 
members 
 
81.25 
(n = 39) 
50.00 
(n = 10) 
72.06 
(n = 49) 
SLE resource list for the clinician 83.33% 
(n = 43) 
70% 
(n = 14) 
 
83.82% 
(n = 57) 
Support group contacts 
 
85.42 
(n = 41) 
55 
(n = 11) 
76.47 
(n = 52) 
Other 
 
   
Contact info of specialists 
 
0.00 
(n = 0) 
5.00 
(n = 1) 
5.00 
(n = 1) 
 
Signs and symptoms 
 
0.00% 
(n = 0) 
5.00% 
(n = 1) 
5.00% 
(n = 1) 
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Open-Ended Comments 
 
The final question of the survey permitted the respondent to add questions or 
comments regarding the content of the survey. The comments are transcribed below:  
“Is this the same as plain old lupus” (graduate student)? 
 
We do not see many of these patients . . . but when we do it is important to 
know what evaluations to provide and be able to counsel these patients on the 
disorder and its progression. Additionally, it is essential to begin rehabilitative 
treatment ASAP [as soon as possible] and be able to explain why/how and 
what will be necessary in the future. (licensed audiologist) 
 
“Most rheumatologists do not know or inform their patients that Plaquenil is ototoxic 
and worse for some patients than others and requires education and monitoring” 
(licensed audiologist). 
Is systemic lupus erythematosus a specific type of lupus, or is it the medical 
name for lupus? I had to Google this. You could have put a brief explanation 
of what SLE [systemic lupus erythematosus] is at the start of your survey to 
clarify this point, but you didn’t. Also, you could have had more questions 
with ‘I don’t know’ as possible answers, because without that option I had to 
randomly choose something and I don't know how those guesses will bias your 
statistical analysis. (licensed audiologist) 
 
Not a comment about providing care to patients, but rather feedback on the 
survey—You did not provide enough opportunity to respond “I don’t know.” 
That may skew your results. When not provided the opportunity to respond “I 
don’t know” I guessed. If the purpose of the study is to determine the state of 
knowledge of currently practicing audiologists, without “I don’t know” as an 
option, you may overestimate the awareness of this condition. It may also be 
helpful for you to know whether someone practicing in a “medical setting” is 
practicing in an adult focused facility, a pediatric focused facility or a facility 
that provides services across the lifespan. Pediatric audiologists may not 
encounter this condition. (licensed audiologist) 
 
Summary 
 
 These outcomes have identified subject areas in which the respondents were 
knowledgeable about SLE and areas where improvement can occur. The general 
consensus is that audiologists and graduate students were aware of the disease and the 
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potential that a hearing loss of an autoimmune basis can develop. However, when it 
came to the concept of what additional services and monitoring this patient group may 
require, respondents were unsure and hesitant of their approach. For instance, 
respondents on average were more likely to disagree that they are confident in their 
understanding of SLE. This was also seen in with the counseling aspect, that the 
respondents were likely to disagree that they would be able to appropriately counsel 
someone with SLE.  
 When the respondents were permitted to select what audiometric tests to add to 
the standard test battery when a patient with SLE is seen for a hearing evaluation, 
EHFA and DPOE were the tests that were selected the most. Another takeaway from 
the responses is that a protocol is needed. When the provided the option, both groups 
responded that it would be useful in the clinic. Other resources were also requested, 
such as a resource list and a list of support groups, but the highest selected option was 
to have a universal protocol available. Overall, according to the survey responses there 
is an awareness of the disease but in terms of follow up, graduate students and 
licensed audiologists use a variety of methods to provide care to this patient 
population. 
 
56 
 
 
 
 
 
 
CHAPTER V 
 
DISCUSSION 
 
Experience of Providing Care 
 
 One component of this research was to identify the knowledge of hearing loss 
associated with systemic lupus erythematosus (SLE) within the groups of practicing 
audiologists and audiology graduate students. Respondents of both groups were 
generally aware of SLE and the relationship of SLE with hearing loss. Graduate 
students were more likely to report having first learned of SLE from a personal 
relationship. Practicing audiologists on the other hand reported learning of SLE from 
another health care professional.   
 Only 31% of both groups combined reported that they first learned of hearing 
loss associated with SLE from graduate school courses. Another factor to consider is 
that this topic area is fairly new in the field of audiology, bearing in mind that the 
majority of the published research on this topic has been within the past decade. For 
instance, the most recent prevalence studies that were completed by the Centers for 
Disease Control and Prevention were published between 2014 and 2017 (Dall’Era et 
al., 2017; Izmirly et al., 2017; Lim et al., 2014; Somers et al., 2014).  
 Overall, this is representative that some audiologists and graduate students may 
have to rely on first-hand clinical experiences or other healthcare providers to be 
introduced to this topic. The respondents also reported a lack of confidence in 
counseling patients with SLE. This may also relate back to the lack of formal training 
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in the disorder. Audiology graduate programs may need to expand their course content 
to include SLE as a relevant clinical pathology and equip audiologists to counsel SLE 
patients. 
 As indicated by this current research study, 59% of licensed audiologists and 
92% of graduate students do not have experience providing care to patients with SLE. 
This is anticipated with graduate students, considering that these individuals are in the 
early stages of their clinical experience. Approximately 40% of licensed audiologists, 
on the other hand, did recall having this background. While it is not anticipated that 
the audiologist will be presented with a specific case such as this on a regular basis, 
the concern is that this may result in the clinician not taking necessary means of care 
specific to this population because of the irregular exposure. Considering that there is 
a moderate to high prevalence of hearing loss in patients with SLE, it is critical that 
the audiologist have resources to refer to if the time comes around that the audiologist 
sees a patient within this population (Rahne et al., 2017). 
 It was somewhat surprising in this digital era to note that electronic media, 
peer reviewed journal articles, or other print resources such as books were not more 
commonly flagged (~1%, n = 5) as an initial source on SLE. It was beyond the scope 
of this research study to review available resources, but it may be useful to provide 
links to existing resources on professional organization websites and publicize on 
social media frequented by audiologists and audiology graduate students. An 
abbreviated list of resources is available in Appendix C that an audiologist can utilize.  
 Seven questions regarding expected audiologic symptoms and hearing loss 
characteristics were presented to determine the familiarity of graduate students and 
licensed audiologists with this subject area. These questions were forced-choice and 
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did not provide an “I don’t know” option. The purpose of this formatting was to 
capture what direction the respondent was leaning towards. An answer key to these 
questions has been included in Appendix D.   
 The majority of both groups were able to correctly identify that the hearing 
loss tends to be sensory or neural; 86% with graduate students and 87% of licensed 
audiologists that is displayed in Table 5. Similar outcomes were observed to the 
questions focusing on disease duration and degree of hearing loss, that vertigo can be a 
symptom, and whether SLE influence by genetic and environmental factors. 
 When it comes to these topic areas, audiologists and graduate students 
generally have the right mindset; however, this does not directly reflect how confident 
the respondents were in their selection. Reflecting on the outcomes of the sider scales 
of the attitudes section, both groups believed that they did not have a high degree of 
confidence with their knowledge and understanding of SLE as well as the confidence 
in their skills to counsel a patient with SLE. As a consequence, the respondents were 
able to perform well with a subset of these questions; however, their confidence may 
be wavering. 
 The question on whether the hearing loss tends to be bilateral or unilateral 
reflected that respondents tended to select the bilateral only option: 41% of graduate 
students and 37% of licensed audiologists. Similar outcomes were associated with the 
questions on the susceptibility of patients with SLE to develop a hearing loss and 
correctly determining that hydroxychloroquine can be ototoxic. It appears that current 
audiologic resources may need to provide greater focus on these topic areas. 
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Need for Clinical Resources 
 There was an overwhelming consensus from both respondent groups that 
additional SLE-related resources are needed in the clinic. There was an agreement 
from both groups that they were not confident with their knowledge and understanding 
of SLE.  
Development of a Clinical Protocol 
 Graduate students and practicing audiologists agreed that a clinical diagnostic 
and monitoring protocol would be desirable to guide the evaluation and care of 
patients with SLE. At this time, a protocol or guideline addressing the audiologic care 
of patients with SLE has not been developed by any professional organization (e.g., 
American Academy of Audiology or American Speech-Language Hearing 
Association). Professional assessment and monitoring guidelines would result in a 
peer-reviewed agreement of how this patient population should be cared for by 
audiologists. The existence of a peer-reviewed clinical protocol or guideline would 
provide an additional opportunity to educate audiologists and graduate students 
regarding hearing loss in patients with SLE. The following sections address the 
clinical components that might be integrated into the guideline. 
Case History 
The development of a protocol would not be absent of its challenges. Each 
patient with SLE can vary in system-wide symptoms and variability is expected with 
regard to auditory symptoms as well (Al-Sukaini et al., 2014). Furthermore, symptoms 
can change over time, requiring that regular comprehensive updates on patient 
symptoms to be updated at each visit.  
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 The case history portion of the protocol should be as comprehensive as 
possible in the instance that symptoms change in the future. Questions should inquire 
about the time of SLE diagnosis, considering that patients diagnosed with SLE early in 
their lives exhibit significantly decreased auditory thresholds that are unrelated to 
presbycusis (Maciazczyk et al., 2011).  
 Moreover, features of tinnitus should be recorded at this time, as this could 
determine whether additional evaluations are needed. The research suggests that 
tinnitus symptoms are prevalent in patients with SLE; therefore, it should be 
documented as soon as possible (Karatas et al., 2007; Maciazczyk et al., 2011). With 
research suggesting nearly half of patients with SLE experiencing bilateral tinnitus, 
the audiologist should anticipate counseling the patient that the cause of the symptom 
is related to their autoimmune disease (Maciazczyk et al., 2011). 
 Vertigo is also a common feature. The audiologist needs to anticipate 
counseling the patient that the pathogenesis of the vertigo symptoms may be related to 
their SLE. The temporal bone study completed by Kariya et al. (2016) have supported 
this concept of disease vestibulotoxicity and Gomides et al. (2007) identified a rate of 
31.1% of patients with SLE who were experiencing vestibular symptoms. As an 
audiologist, the case history should incorporate questions addressing any current 
vertigo features are experienced by the patient with SLE.   
 A case history question devoted to the identification of current medications 
should also be included. This could come in the simple form of a checklist to allow the 
audiologist to quickly review with the patient. A concerning finding from this present 
research is that respondents of both groups were not aware of the ototoxic effect of 
Plaquenil (Seckin et al., 2000). Incorporating a standard sub-set of questions related to 
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Plaquenil administration to the protocol would allow the audiologist to keep in mind 
of not only the immune factors at large, but also the potential need for ototoxicity 
monitoring.  
 Respondents expressed the importance of knowing the interdisciplinary team 
that is overseeing the patient. This is an additional section to be highlighted in the case 
history intake. What is paramount is determining the rheumatologist treating the 
patient, especially if the audiologist has concerns that need to be communicated to the 
physician related to changes in auditory functioning, especially in the context of 
ototoxicity.  
Additions to the Standard 
Audiometric Battery 
An SLE clinical protocol not only should provide guidelines to case history 
intake, an outline of the audiometric battery should also be included. The predominant 
view from respondents in terms of evaluating patients with SLE supported the 
inclusion of additional tests beyond the standard audiological test battery. A review of 
the literature suggests that an SLE protocol should include the additional test 
measurements of extended high-frequency audiometry (EHFA) and distortion product 
otoacoustic emissions (DPOAEs) (Botelho et al., 2014; Lasso de la Vega et al., 2017). 
Both of these tests permit the audiologist to identify early features of a sensorineural 
hearing loss and document any sub-clinical auditory damage. Furthermore, 
considering that the malarial pharmaceutical hydroxychloroquine or Plaquenil used 
with patients with SLE has the potential of causing the hearing loss, especially in the 
higher frequencies, these tests would offer the opportunity to monitor the patient in 
terms of ototoxicity (Chansky & Werth, 2017; Seckin et al., 2000). 
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 Incorporating EHFA and DPOAEs would provide general information 
regarding neural functioning and an additional diagnostic measure to use if changes in 
hearing sensitivity occur. Published research has indicated that the hearing loss can 
become worse over time (Cordeschi et al., 2004; Sperling et al., 1996). Reflecting on 
the current published research, it is critical that clinicians within the audiology field 
focus incorporate EHFA and DPOAEs specifically for this patient population.  
Monitoring Schedule 
Another challenge in the establishment of a clinical protocol would be 
determining how often audiological evaluations should be repeated. The general 
practice of audiologists and graduate students is to schedule annual hearing 
evaluations. Having an annual schedule may be an appropriate method considering 
that the patient may need to attend many other healthcare appointments in the context 
of monitoring their health.  
 A review of the literature also indicates a lack of evidence supporting 
fluctuating hearing loss associated with systemic lupus erythematosus (Di Stadio & 
Ralli, 2017; Rahne et al., 2017). Therefore, the nature of the hearing loss tends to be 
more progressive and unlikely for the thresholds to recover. As a result, the 
audiologist can anticipate a more standardized monitoring protocol that does not have 
to incorporate additional appointments in order to document the fluctuation. 
 Some respondents noted that they advise SLE patients to contact them for 
earlier testing if the patient notes subjective changes in hearing or concerns about their 
hearing arise before the routine annual test. In the case of sudden sensorineural 
hearing loss (SNHL), additional hearing evaluations may need to be scheduled in 
order to confirm the sudden hearing loss or to document the fluctuations in hearing 
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sensitivity. The research suggests that patients with SLE have a higher rate of sudden 
SNHL than individuals without the disease (Lin et al., 2013). Recent publications have 
identified even higher rates of sudden SNHL in patients with SLE who also have 
additional disorders, such as rheumatoid arthritis and antiphospholipid syndrome 
(Riera et al., 2019; Xie et al., 2019).  
 Considering the association of sudden SNHL, SLE, and the presence of 
comorbid diseases, the audiologist may need to have an active role in clinical team 
providing the patient care. This may require the audiologist to collaborate with the 
rheumatologist or primary care physician in order to determine the best monitoring 
schedule. The monitoring schedule may also be impacted by insurance 
recommendations and reimbursement or referral requirements as well.  
Professional Consensus 
A professional consensus is needed to generate an interdisciplinary clinical 
protocol. The best approach is to have a team of rheumatologists, otolaryngologists or 
otologists, and audiologists who have extensive experience in providing care to 
patients with SLE collaborate on a peer-reviewed guideline. This will permit a more 
finite step-by-step course of action and eliminate potential conflicting opinions 
regarding patient care. This document may also inform insurance companies with 
regard to coverage for audiological services. 
Additional Resources 
 In addition to the development of a protocol, there were other requests from 
the respondents to have a list of SLE support groups to provide to patients. Appendix 
E includes a handout to provide to patients who express interest in finding online and 
local resources. These resources also allow the audiologist to read patient stories and 
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become connected to other medical professionals that support patients with SLE. 
Appendix E provides a list of these groups, all of which have online resources. It is 
encouraged to have the audiologist become familiar with whether there are in-person 
resources within their general area, as the availability of this type of support varies 
depending on where the patient resides geographically. It should be noted that there is 
an opportunity for the protocol to recommend the audiologist to provide these 
resources and serve as a reminder to the audiologist of the availability of this 
information.  
 Furthermore, a brief list of relevant research articles has also been provided in 
Appendix E as a starting point for audiologists and graduate students to learn 
additional information. This is beneficial for audiologists who may have access to 
PubMed or an alternative database. Appendix E also provides a table of other online 
resources for an audiologist to become acquainted with SLE characteristics. A list of 
research articles to have in the clinic was requested by the majority of respondents and 
this appendix would also address the concern that audiologists and graduate students 
know which resources to utilize. While the references section of this research provides 
a comprehensive list of resources, this abbreviated list to have on hand in the clinic as 
a guide may be advantageous as a quick resource. These resources and protocol are to 
provide audiologists and audiology graduate students a set of materials so that they 
may adequate care to a group of patients that can vary in audiologic symptoms. 
Accessibility to New Research 
 A search of lupus on the frequently used resource for audiologist continuing 
education credits, AudiologyOnline.com, determined that there are no current 
publications or presentations regarding hearing loss and autoimmune diseases. On the 
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other hand, a search of diabetes found four links; two of which were a series of 
presentations outlining hearing loss in chronic disorders (which included diabetes). 
There may be a benefit in the development of a similar presentation: An informational 
compilation of autoimmune diseases associated with hearing loss that included SLE 
and conditions such as Wegener’s granulomatosis, rheumatoid arthritis, Sjogren’s 
disease, and Cogan syndrome. Again, taking into account that the SLE research is 
relatively new, an electronic continuing education presentation that was easily 
accessible would allow audiologists to keep up to date. 
Initial Development of a Protocol 
 Appendix F outlines a very general protocol that can provide the initial 
recommendations of audiologic care for a patient with SLE. Sections include what 
questions to incorporate into the case history, what baseline audiometric battery 
should be used, and what to keep in mind when determining a monitoring schedule. 
Again, additional research needs to be completed for the development of a formal 
protocol but the intention of this current protocol is to provide a temporary guideline 
for audiologists and graduate students.  
Study Limitations 
 A number of study limitations were identified throughout this research study. 
The majority of the respondents were enrolled in graduate school at the time they 
completed the survey. Potentially, a larger focus of practicing audiologists would have 
provided a more dynamic perspective of experiences of treating patients with SLE. 
Furthermore, the survey was distributed using an electronic link. As a result, the 
survey was not accessible to audiologists who rarely use technology during their 
personal time or do not have Facebook. It is anticipated that more respondents would 
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have been reached if letters with the survey link were handed out in person at 
audiology conferences.  
 Other limitations are in relation to the structure of the survey. Noted in the 
open comments section at the end of the survey, the concept of not providing an “I 
don’t know” option was mentioned. During the development of the survey, having this 
option was contemplated. It was concluded to have a closed set of questions in order 
to determine what most likely action they would take. Bearing in mind that this is a 
topic just being integrated into the field of audiology, providing an “I don’t know” 
option would not have captured what direction the respondent was leaning towards. As 
a result, it may have prevented participants from fully participating in the survey and 
leaving the survey incomplete. Additionally, the question “are you familiar with the 
autoimmune disease by the name of systemic lupus erythematosus?” may have 
deterred respondents who were not confident on the subject area. Ideally, the survey 
would have indicated “we are still interested in your survey responses.”   
 It would have been beneficial to clarify in the survey that SLE is commonly 
referred to as simply lupus. While there are multiple types of lupus, such as discoid 
lupus, there are higher rates of SLE and as a result is what is typically being referred 
to when the term lupus is used.  
Future Research 
 This research study is the first known study of a qualitative design addressing 
how audiologists and audiology graduate students provide care to patients with SLE. 
Additional research should identify which medical or audiological clinics have a 
clinical protocol and gain additional information regarding the actual administration of 
audiologic care to SLE patients. It may be feasible to mine the diagnostic 
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(international classification of diseases) and audiological procedure (current 
procedural terminology) codes submitted to third-party payers for a better sense of 
what care is being provided and the timeline for evaluations. Lastly, it might be 
informative to survey patients with SLE regarding their audiological care and 
experiences. Faculty surveys regarding audiology curriculums and course syllabi 
might also provide a clearer picture regarding the inclusion of SLE as an educational 
topic in graduate audiology training programs. The information provided in 
Appendices E and F is also beneficial for integration into coursework. 
Conclusion 
 This sample comprised of audiology graduate students and licensed 
audiologists has provided a snapshot of the general approaches these two groups are 
implementing in the audiologic care of patients with SLE. This study has identified 
that new and experienced audiologists need more information and resources in order 
to provide appropriate care. The current status of both groups is that there is a general 
awareness of the disease but a limited degree of confidence in providing care. These 
outcomes highlight the opportunities to develop a clinical and diagnostic protocol, to 
develop additional trainings, and the need to have this topic integrated into current 
graduate school courses. With the recent publications of SLE prevalence in the United 
States clarifying how patient denizens have this disease, it has become clearer that 
there is a likelihood that an audiologist will provide care to this population group 
during their career providing direct-patient care.   
 This study has underlined the opportunity for a group of professionals to work 
on a peer-reviewed clinical protocol. Further research should identify the appropriate 
actions an audiologist must complete in order to ensure that sufficient long-term 
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audiologic care can be provided to patients diagnosed with SLE. The need for 
standardized care and trained audiologists is critical for patients with SLE. 
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Question 
 
 
Correct answer 
 
How susceptible is a patient with systemic lupus 
erythematosus to hearing loss? 
 
What type of hearing loss is commonly associated 
with hearing loss from SLE autoimmune responses? 
 
For patients with SLE, does the hearing loss tend to 
be bilateral or unilateral? 
 
Do you believe that the duration of SLE and the 
degree of hearing loss are correlated? (e.g., the longer 
a person has had SLE, the poorer the hearing 
 
Can SLE patients experience vertigo that is attributed 
to the presence of the autoimmune disease? 
 
SLE is thought to arise in patients from which of the 
following factors: 
 
The following medications are used in the treatment 
of SLE. Based on your knowledge, which ones can be 
ototoxic, if any? Selected choice. 
 
 
Moderate to high 
susceptibility 
 
Sensory & Neural 
 
 
More so bilateral, but 
unilateral has been reported 
 
Yes 
 
 
 
Yes 
 
 
Both genetic and 
environmental factors 
 
Hydroxychloroquine 
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SUPPORT GROUP RESOURCE 
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Name of the Group Description Connections 
to Local 
Support 
Services? 
Advocating 
Opportunities? 
Lupus Foundation of 
America 
 
https://www.lupus.org/ 
 
The national lupus 
organization that has 
the mission of 
providing research 
updates, opportunities 
to join research trials, 
and educate the 
general public of the 
disease.  
Yes Yes 
Molly's Fund Fighting 
Lupus 
 
https://kaleidoscopefightingl
upus.org/ 
 
A nonprofit group that 
informs patients and 
professionals of the 
disease and oversees 
the development of 
government advocacy 
events.  
No Yes 
Lupus Warriors 
 
Private Facebook Page 
Provides patients and 
family members 
opportunities to 
connect with other 
lupus patients and 
pose general questions 
or concerns.  
Yes Yes 
Daily Strength Lupus 
Group 
 
https://www.dailystrength.or
g/group/lupus 
 
Online blog to become 
connected with other 
lupus patients and 
family members  
No No 
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Case History 
 1. Hearing Sensitivity Characteristics   
  a. Have you experienced a sudden change in hearing sensitivity in one ear 
        or both ears? 
  b. When did you first notice a change in your hearing? Has it been slowly  
        progressive or sudden? 
 2. Auditory Symptoms 
  a. Tinnitus 
   1). Do you experience tinnitus in one ear or in both ears? If so,  
         when did this first start? 
   2). Over time, what has been your exposure to high-intensity  
         sounds in occupational and recreational environments? 
  b. Vertigo 
   1). If you experience any dizziness or imbalance, when does it  
        occur? Does your dizziness coincide with flare symptoms? 
 3. Medications 
  a. What medications are you currently on? 
  b. What is an estimated amount of time you have been taking  
       hydroxycholorquine (Plaquenil)? 
 4. Systemic Lupus Erythematosus Characteristics 
  a. Approximate time of diagnosis? 
  b. Comorbid disorders/diseases?  
  c. When was your last flare? 
 5. Identification of Medical Team 
  a. Rheumatologist? 
  b. Other professionals? 
Baseline Audiometric Battery 
 Recommended  
  1. Otoscopy 
  2. Tympanometry 
  3. Acoustic reflex testing  
  4. Distortion Product Otoacoustic Emissions (DPOAEs) 
  5. Pure tone audiometry (250-8000Hz) via air conduction and bone  
       conduction 
  6. Extended high-frequency audiometry (EHFA) following SRO protocol 
  7. Speech recognition threshold (SRT) testing 
  8. Word recognition (WRS) testing  
 Case Dependent 
  1. If experiencing vertigo symptoms, possibly an VNG 
  2. Tinnitus matching protocol if tinnitus is reported 
Monitoring Schedule 
 1. Consider every six months if the patient has a comorbid autoimmune disease 
 2. Annual hearing with counseling that emphasizes that if a sudden hearing loss is  
      perceived that immediate follow up with the primary care physician and  
      rheumatologist is crucial  
 3. Consider contacting the rheumatologist to determine monitoring schedule 
Additional Considerations 
 1. Do additional referrals need to be made (ENT, otologist, neurologist)? 
 2. What releases of information need to be completed? 
 
 
